Full Name
Mr François Houÿez
Job Title
Director of Treatment Information and Access
Company/Organisation
European Organisation for Rare Diseases
Speaking At
Speaker Bio
François Houÿez has worked as a patient advocate since the early 1990s (HIV/AIDS, Act Up -Paris and EATG) and joined EURORDIS in May 2003. He now works as Information & Access to Therapies Director & Health Policy Advisor.
He represents EURORDIS at the Patients’ and Consumers’ Working Party at the European Medicines Agency (EMA). He also represents EURORDIS at the Health Technology Assessment Network, and in CIOMS Working Group XI on Patient Involvement in the Development and Safe Use of Medicines.
François supervises EURORDIS's programme for Community Advisory Boards (EuroCAB) and the European Network of Rare Diseases Help Lines.
He pioneered patient advocacy with the European Medicines Agency as part of the first patients’ delegation that engaged dialogue with the Agency back in 1996 and has continuously been involved in the agency activities during the last 26 years.
François compiles trend information, and regularly fields questions from rare disease patients having issues with access to treatments (especially marketing authorisations, health technology assessment/pricing/reimbursement, compassionate use, shortages, and pharmacovigilance) and please feel free to contact him about these topics.
François is also a patient.
He represents EURORDIS at the Patients’ and Consumers’ Working Party at the European Medicines Agency (EMA). He also represents EURORDIS at the Health Technology Assessment Network, and in CIOMS Working Group XI on Patient Involvement in the Development and Safe Use of Medicines.
François supervises EURORDIS's programme for Community Advisory Boards (EuroCAB) and the European Network of Rare Diseases Help Lines.
He pioneered patient advocacy with the European Medicines Agency as part of the first patients’ delegation that engaged dialogue with the Agency back in 1996 and has continuously been involved in the agency activities during the last 26 years.
François compiles trend information, and regularly fields questions from rare disease patients having issues with access to treatments (especially marketing authorisations, health technology assessment/pricing/reimbursement, compassionate use, shortages, and pharmacovigilance) and please feel free to contact him about these topics.
François is also a patient.
